Patient Blood Management in Orthopedic Surgical Patients in Turkey

Status Recruiting

Clinical Trial Summary

Transfusion practice for surgical patients has changed from replacing surgically lost blood with allogeneic blood transfusions to implementing strategies that reduce transfusion requirements. Patient Blood Management (PBM), which is "the timely application of evidence-based medical and surgical concepts designed to maintain haemoglobin concentration, optimize hemostasis and minimize blood loss in an effort to improve patient outcome. There is mounting evidence that multimodal patient blood management (PBM) programmes can be effective at improving postoperative outcomes and reducing perioperative blood transfusions and costs The Turkish Society of Anaesthesiologists PBM Task Force has been working on this subject and studied transfusion practice throughout all through the peri-operative periods. Unfortunately we documented a high transfusion rate in major surgical patients in Turkey. One of the surgeries, that has high transfusion rate, was orthopaedic surgery. According to our recent data we planned to implement PBM in major orthopaedic surgical patients and evaluate the effects PBM in transfusion rate and patient outcomes. While some elements of PBM have a strong evidence base in hip or knee replacement, such as the use of tranexamic acid (TXA) the evidence for preoperative anaemia optimisation with iron is less robust. Implementing PBM all through the operative period gains more importance.

Clinical Trial Description

Active PBM Implementation: Patients undergoing hip or knee arthroplasty will be treated as follows: PBM will be performed as shown in the graph below "PBM Implementation Group". Active PBM group will be treated for preoperative anemia at least 3 weeks prior to the surgical intervention as per the "Anemia Algorithm" below Other pillars of PBM will be also performed to the treatment group as per the visual graph below. The parameters included in the PBM pillars will be recorded including preoperative anemia parameters. Postoperative variables and parameters related to complications will be recorded. For the control group (Non-PBM group), the data of the patients, will be prospectively included. The 1:1 ratio of the control and active groups will be done. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05319223
Study type	Observational
Source	ERAS Turkey Association
Contact	Cigdem YILDIRIM GUCLU
Phone	+905324576648
Email	drcigdemyldrm@yahoo.com.tr
Status	Recruiting
Phase
Start date	February 1, 2022
Completion date	December 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02229331` - Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.
Completed	`NCT03258697` - The Pharmacokinetics and Effectiveness of Local LevoBupivacaine Injection on Primary Total Joint Replacement Model.	N/A
Recruiting	`NCT05187936` - Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy
Completed	`NCT04206033` - Hemophilia and Bone Metabolism: Study of Monocytic Populations and Inflammatory Proteins
Completed	`NCT04024176` - Gait Analysis in Moderate Hemophiliac Patients (AQM-Hemophile)	N/A
Completed	`NCT06053060` - Evaluation of the Positioning of the Dynacup Cup "One C" Versus "Standard Dynacup"	N/A
Recruiting	`NCT01300715` - An Alternative Technique for Lumbar Medial Branch Radiofrequency: Comparison With the Empirical Technique	N/A
Terminated	`NCT05215600` - Anaverse™ Glenoid System and Its Instrumentation
Recruiting	`NCT04826380` - Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility	N/A
Recruiting	`NCT05591859` - Restoration Anatomic Acetabular Shell Revision Study	N/A
Recruiting	`NCT05295004` - The Effect of Mindfulness Training Before Primary Total Joint Arthroplasty on Sleep Quality	N/A
Completed	`NCT06002139` - Virtual Reality in Orthopedic Rehabilitation	N/A
Recruiting	`NCT05459948` - The Medacta GMK SpheriKA Post-Marketing Surveillance Study
Enrolling by invitation	`NCT04618237` - Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient
Recruiting	`NCT05292339` - Ketorolac in Upper Extremity Tendinopathy and Arthropathy	Phase 4
Completed	`NCT03485170` - PET Imaging of Hemophilic Arthropathy	N/A
Recruiting	`NCT05629130` - Embolization in Hereditary Coagulopathies	N/A
Recruiting	`NCT05840705` - Approach Modification for Total Knee Arthroplasty in Morbidly Obese Patients	N/A
Completed	`NCT06440863` - Postoperative BMI Changes and Functional Outcomes in Knee and Hip Arthroplasty	N/A
Completed	`NCT05217264` - Adaptation of High Activity Arthroplasty Score to Turkish

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Patient Blood Management in Orthopedic Surgical Patients in Turkey — PABMOS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms